Literature DB >> 29880271

Not just heroin: Extensive polysubstance use among US high school seniors who currently use heroin.

Joseph J Palamar1, Austin Le2, Pedro Mateu-Gelabert3.   

Abstract

BACKGROUND: Heroin-related deaths are on the rise in the US and a large portion of heroin overdoses involve co-use of other drugs such as benzodiazepines. A better understanding of heroin polysubstance use patterns could help discern better prevention measures.
METHODS: Data were examined from past-month ("current") heroin users from a nationally representative sample of high school seniors in the Monitoring the Future study (2010-2016, n = 327). We examined how past-month use and frequency of use of various drugs relate to frequency of current heroin use using chi-square and multivariable ordinal logistic regression.
RESULTS: Prevalence of any past-month use of various other drugs (and past-month use 10+ times) tends to increase as the frequency of heroin use increases; however, other drug use tends to decline among those reporting the use of heroin 40+ times in the past month. In multivariable models controlling for demographic characteristics, most levels of alcohol use were associated with decreased odds of higher-frequency heroin use (ps<.05). Nonmedical opioid (aOR = 5.84, p = .037) and tranquilizer (aOR = 14.63, p = .045) use 40+ times in the past month were associated with increased odds of higher-frequency heroin use.
CONCLUSIONS: High school seniors who use heroin also use multiple other drugs. Increases in the frequency of heroin use are associated with shifts in the nature and frequency of polysubstance use, with a higher frequency of heroin use associated with the highest percentage and frequency of use of depressants (nonmedical opioid and benzodiazepine use), compounding the risk of overdose. Prevention measures should consider polysubstance use patterns among heroin-using adolescents.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescents; Benzodiazepines; Heroin; Polysubstance use

Mesh:

Substances:

Year:  2018        PMID: 29880271      PMCID: PMC6198323          DOI: 10.1016/j.drugalcdep.2018.05.001

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  46 in total

1.  Fatal versus non-fatal heroin "overdose": blood morphine concentrations with fatal outcome in comparison to those of intoxicated drivers.

Authors:  Christoph Meissner; Sabine Recker; Arthur Reiter; Hans Juergen Friedrich; Manfred Oehmichen
Journal:  Forensic Sci Int       Date:  2002-11-05       Impact factor: 2.395

2.  Heroin use onset among nonmedical prescription opioid users in the club scene.

Authors:  Hilary L Surratt; Steven P Kurtz; Mance Buttram; Maria A Levi-Minzi; Maria E Pagano; Theodore J Cicero
Journal:  Drug Alcohol Depend       Date:  2017-07-26       Impact factor: 4.492

Review 3.  Adolescent heroin use: a review of the descriptive and treatment literature.

Authors:  Christian J Hopfer; Elizabeth Khuri; Thomas J Crowley; Sabrina Hooks
Journal:  J Subst Abuse Treat       Date:  2002-10

4.  Cognitive impulsivity in cocaine and heroin polysubstance abusers.

Authors:  Antonio J Verdejo-García; José C Perales; Miguel Pérez-García
Journal:  Addict Behav       Date:  2006-07-28       Impact factor: 3.913

5.  Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement.

Authors:  J Ross; S Darke; W Hall
Journal:  Drug Alcohol Rev       Date:  1996-09

6.  Opioid drug poisonings in Ohio adolescents and young adults, 2002-2014.

Authors:  Sarah Caupp; Janine Steffan; Junxin Shi; Krista K Wheeler; Henry A Spiller; Marcel J Casavant; Henry Xiang
Journal:  Clin Toxicol (Phila)       Date:  2018-01-11       Impact factor: 4.467

7.  Differences in Treatment Outcomes between Prescription Opioid-Dependent and Heroin-Dependent Adolescents.

Authors:  Mehran Motamed; Lisa A Marsch; Ramon Solhkhah; Warren K Bickel; Gary J Badger
Journal:  J Addict Med       Date:  2008-09       Impact factor: 3.702

8.  Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin.

Authors:  Avelardo Valdez; Alice Cepeda; Alan Neaigus; Amy Russell
Journal:  Int J Drug Policy       Date:  2007-08-06

9.  Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis.

Authors:  Meredith C Meacham; Abby E Rudolph; Steffanie A Strathdee; Melanie L Rusch; Kimberly C Brouwer; Thomas L Patterson; Alicia Vera; Gudelia Rangel; Scott C Roesch
Journal:  Subst Use Misuse       Date:  2015-10-07       Impact factor: 2.164

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  10 in total

1.  Perceived Risk of Heroin in Relation to Other Drug Use in a Representative US Sample.

Authors:  Joseph J Palamar; Austin Le; Pedro Mateu-Gelabert
Journal:  J Psychoactive Drugs       Date:  2019-06-22

2.  Sexual Orientation Disparities in Prescription Opioid Misuse Among U.S. Adults.

Authors:  Dustin T Duncan; Sophia Zweig; H Rhodes Hambrick; Joseph J Palamar
Journal:  Am J Prev Med       Date:  2018-11-19       Impact factor: 5.043

3.  Trends in Adolescent Heroin and Injection Drug Use in Nine Urban Centers in the U.S., 1999-2017.

Authors:  Sherri-Chanelle Brighthaupt; Kristin E Schneider; Julie K Johnson; Abenaa A Jones; Renee M Johnson
Journal:  J Adolesc Health       Date:  2019-08       Impact factor: 5.012

4.  Role of Acetaldehyde in Ethanol Reversal of Tolerance to Morphine-Induced Respiratory Depression in Mice.

Authors:  Rob Hill; Alexandra Conibear; William Dewey; Eamonn Kelly; Graeme Henderson
Journal:  Adv Drug Alcohol Res       Date:  2022-01-31

5.  Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis.

Authors:  M Eugenia Socías; JinCheol Choi; Stephanie Lake; Evan Wood; Jenna Valleriani; Kanna Hayashi; Thomas Kerr; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-12-17       Impact factor: 4.492

6.  The Polysubstance Overdose-Death Crisis.

Authors:  John F Peppin; Robert B Raffa; Michael E Schatman
Journal:  J Pain Res       Date:  2020-12-15       Impact factor: 3.133

Review 7.  Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.

Authors:  Hanis Mohammad Hazani; Isa Naina Mohamed; Mustapha Muzaimi; Wael Mohamed; Mohamad Fairuz Yahaya; Seong Lin Teoh; Rashidi Mohamed Pakri Mohamed; Mohd Fadzli Mohamad Isa; Sundus Mansoor Abdulrahman; Ravi Ramadah; Mohammad Rahim Kamaluddin; Jaya Kumar
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

8.  Poly-prescription drug misuse across the life course: Prevalence and correlates across different adult age cohorts in the U.S.

Authors:  Jason A Ford; Ty S Schepis; Sean Esteban McCabe
Journal:  Int J Drug Policy       Date:  2020-11-20

9.  Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018.

Authors:  Riley D Shearer; Benjamin A Howell; Gavin Bart; Tyler N A Winkelman
Journal:  Drug Alcohol Depend       Date:  2020-07-02       Impact factor: 4.492

10.  Prevalence and Characteristics of Borderline Intellectual Functioning in a Cohort of Patients With Polysubstance Use Disorder.

Authors:  Jens Hetland; Kirsten J Braatveit; Egon Hagen; Astri J Lundervold; Aleksander H Erga
Journal:  Front Psychiatry       Date:  2021-07-14       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.